LloydsPharmacy Clinical Homecare, a leading provider of home healthcare services in the UK, on Monday announced the appointment of Paul Adams as the
company's new Chief Executive Officer (CEO).
Before assuming his role at LPCH at the end of last year, Adams was leading transformation efforts at DD Group, formerly known as Dental Directory.
With a career spanning over two decades, Adams has held influential positions at Diageo, Smith+Nephew, and served as a CEO for various Private Equity companies.
He has also co-authored "The Little Black Book of Change."
Adams will lead the LPCH's mission to pioneer the delivery of specialist clinical treatment therapies to patients, thereby enhancing patient outcomes within
homecare and community settings while improving accessibility.
The government will on Thursday launch a drive to boost childhood vaccination rates, health authorities said, seeking an "urgent reversal" to a fall in
uptake as the country faces a worsening measles outbreak.
Routine childhood immunisations in Britain for diseases including measles, mumps and rubella, diphtheria and polio, have been falling gradually over the past
decade, but dipped more sharply after the Covid-19 pandemic, mirroring a global decline.
Last year UNICEF said people worldwide had lost confidence in the importance of routine childhood vaccines during the pandemic, with misinformation, dwindling
trust in governments and political polarisation contributing to rising hesitancy.
Britons will begin seeing adverts from next week across various media, including a television campaign featuring children reminding parents of the risk of missing
out on vaccinations, the UK Health Security Agency (UKHSA) said.
"We need an urgent reversal of the decline in the uptake of childhood vaccinations to protect our communities," UKHSA chief executive Jenny Harries said in a
statement.
With 118 new cases confirmed by the UK Health Security Agency (UKHSA), the total number of measles cases reported in England since 1 October 2023 has gone
up to 465.
According to the latest data published by the agency, West Midlands continues to see a disproportionately high rate of infections, with a sharp rise in case
numbers over the last six weeks, mainly driven by cases in Birmingham.
In England, there were 17 laboratory-confirmed measles cases in October, 42 in November, 161 in December, 240 in January 2024.
Five more cases were confirmed last week, according to the measles statistics updated by UKHSA on 8 February.
More than 70 per cent (329 of 465) of total confirmed cases were reported from the West Midlands, 13 per cent (62 of 465) from London, seven per cent (32 of 465)
in Yorkshire and The Humber, and the remaining cases from other regions of England.
The UK government on Wednesday (7 February) announced a new plan to ensure faster, simpler and fairer access to NHS dental care across England.
Supported by £200m of funding, the plan aims to deliver more than 1.5 million additional NHS dentistry treatments or up to 2.5 million NHS dental appointments
for patients over the next 12 months
NHS dentists will be offered a 'new patient' payment of between £15-£50, depending on treatment need, to treat new patients who have not seen a dentist in two
years or more.
Additionally, one-off payments of up to £20,000 will be given to around 240 dentists for working in under-served areas for up to three years.
This is to "attract new NHS dentists and improve access to dental care in areas with the highest demand," NHS England said in a statement released on Wednesday.
A recent study presented at the European Congress on Obesity in Venice sheds light on the detrimental effects of obesity on workplace absenteeism and economic
productivity.
The analysis, encompassing data from millions of workers across Europe, reveals a direct correlation between body mass index (BMI) and the likelihood of taking sick
leave.
According to the study, obese individuals are up to twice as likely to take time off work due to health issues compared to those of a healthy weight.
The increased sick notes among obese individuals is attributed to various complications associated with obesity, including joint pain, diabetes, depression, and
heart disease.
In the United Kingdom, where obesity rates are among the highest in Europe, the impact of obesity on workplace absenteeism is particularly pronounced.
A groundbreaking research project has revealed that the public is urging the government to prioritise primary and community care over hospitals.
The study also found a strong public willingness to pay higher taxes to enhance NHS services.
The Health Foundation and Ipsos UK conducted the research, combining nationwide polling with in-depth public deliberative workshops.
These workshops, held in King's Lynn, Leeds, and London, constitute one of the most comprehensive public consultations about the future of the NHS in England.
The study published on 16 May underscores the public's desire for a redistribution of NHS resources. If the NHS budget remains unchanged, 60 per cent of those
polled believe the government should focus on improving access to community-based services like general practice and dentistry.
Reena Mehta, consultant pharmacist in the Critical Care team at NHS King's College Hospital, has been announced as chair of the Learning Division for the
Intensive Care Society.
Mehta took up the post with effect from 8th April, and is the first pharmacist to hold the role of Chair of the Learning Division within the Society.
"It is a privilege to be part of the Society and support its life-saving work to enhance our understanding of critical illness and deliver better care to patients,"
"The intensive care community is made up of multiple professions, each playing a vital role within the critical care team, and I am extremely proud to be the first
pharmacist appointed to this important role."
In her role as chair of the Learning Division, Mehta will oversee the content of the Society's study days and be responsible for exploring new opportunities for the
Intensive Care Society to provide training for our multi professional intensive care community.
Thousands of cancer patients in England are set to gain fast-tracked access to personalised cancer vaccine trials through a new National Health Service(NHS)
initiative, the Cancer Vaccine Launch Pad.
This groundbreaking service aims to find new life-saving treatments by matching eligible patients with clinical trials across the country.
The first patient to receive a personalised vaccine for bowel cancer is Elliot Phebve, a 55-year-old lecturer, treated at University Hospitals Birmingham NHS
Foundation Trust.
Phebve, diagnosed through a routine health check, underwent surgery and chemotherapy before joining the trial.
Sponsored by German biotech company BioNTech SE, the colorectal cancer vaccine trial is one of several taking place across NHS trusts.
The University of Oxford's Centre for Research Equity (CfRE) has entered into a historic partnership with the Health and Social Care Research and
Development (HSC R&D) Division in Northern Ireland to advance health equity across the region and ensure everyone benefits from healthcare advancements.
Unveiled during an event at Parliament Buildings in Stormont Estate on Wednesday, this groundbreaking partnership makes Northern Ireland the first UK region
to partner with CfRE.
Supported by the Department of Health Northern Ireland and key health and social care agencies, the partnership aims to improve health outcomes and reduce
disparities through collaborative research.
Northern Ireland's Health Minister, Mike Nesbitt, highlighted that this new partnership represents "a significant step forward in efforts to address health
inequalities" in the region.
"By bringing together leading experts and resources from across sectors, we can work towards conducting research that truly benefits all of our communities," he
said.
The World Health Organization (WHO) reiterated its concerns about tobacco companies' continued targeting of young people through various channels such as
social media, sports, and music festivals, as well as the introduction of flavored products.
In a joint report with industry watchdog STOP released on Thursday, the WHO accused these companies of attempting to ensnare a new generation in nicotine addiction.
While facing stricter regulations on traditional cigarettes, major tobacco firms and newcomers have turned to alternatives like vapes, arguing they are intended for
adult smokers.
However, the WHO and STOP highlighted in their report that these products often appeal to youth, with their attractive designs and fruity flavors making them more
appealing to children than to adults in many countries.
Expressing apprehension over the concerning decline in the nursing workforce, Sir Julian Hartley, CEO of NHS Providers, urged the forthcoming government
to bolster investment in nursing education and enhance support for student nurses.
Recent analysis from the Royal College of Nursing (RCN) has projected that the NHS Long Term Workforce Plan will fall short by 10,000 new nurses by 2025.
Commenting on the RCN analysis, Sir Hartley underscored the critical importance of having an adequate number of nurses to ensure the delivery of safe,
high-quality patient care.
"Without enough nurses, the delivery of safe, high-quality patient care is compromised," he said.
He cautioned that the predicted shortfall in nurses would exacerbate existing pressures on the NHS, resulting in long waiting times, delayed treatments and
staff burnout.
We've all heard of Dry January, but that doesn't mean that the first month of the year is the only one where you can quit the booze for an intermittent period.
No, you can do it anytime and often it can be just the push you need to review your relationship with the hard stuff.
More and more of us are developing problematic relationships with alcohol, and the likes of addiction are on the rise. Attempting an alcohol detox can be a good way
to understand your relationship, although if you are heavily reliant on the substance, it is worth doing it in a controlled and safe environment with professional
care.
That said, for many of us that isn't the case and giving up for a month can see a wealth of changes in your life. So, what can you expect exactly?
Improved Physical Health
First and foremost, your physical health will improve as a result. Alcohol is known for its empty calories and sugar. It's why many of us develop beer bellys and
gain weight when we drink regularly.
Ultimately, by cutting those calories, you'll find it much easier to shed weight and the results can happen relatively quickly. What's more, as alcohol slows down
metabolism and can often lead to poor food choices like takeaways, eliminating it makes it much easier to manage your weight.
A man has been sentenced to three and a half years in prison for illegally importing and distributing unlicensed medicines from India, the Middle East,
and the Far East.
Antoine Christopher Kolias, 31, received his sentence at Southwark Crown Court on 28 June after being found guilty of criminal activities in May.
The Medicines and Healthcare products Regulatory Agency's (MHRA) Criminal Enforcement Unit (CEU) led the investigation, dubbed Operation Bentley.
Kolias was discovered to be acting both as a distributor for an established unlicensed medicines dealer and running his own illicit business.
He was involved in the sale of sildenafil citrate, the active ingredient in Viagra, as well as Class C drugs including tramadol, zopiclone, and pregabalin between
2018 and 2019, and again between 2020 and 2021.
The Association of the British Pharmaceutical Industry (ABPI) has laid out a series of urgent actions it wants the newly elected Labour government to
implement within its first 100 days in office.
Among the top priorities, the ABPI has emphasised the urgent need to appoint a new Chair and Chief Executive for the Medicines and Healthcare products Regulatory
Agency (MHRA).
Additionally, the ABPI has urged the new government to launch the Life Sciences Manufacturing Capital Grants Facility without delay.
Other measures the ABPI wants Labour to prioritise include:
Rapidly passing outstanding UK clinical trials legislation to enhance the UK's attractiveness for inward investment, including into research within the NHS.
Increasing commercial flexibility in the NHS England Commercial Framework for New Medicines to remove barriers for companies to launch new medicines and indications
so that NHS patients can access the latest innovative medicines.
"Barcodes are becoming obsolete, so we needed a unique selling point," comments Business Development Manager at Huxley Europe, Richard Wertheimer,
celebrating the relaunch of its HuxQ10 capsules.
Now boasting a rare triple certification, HuxQ10 capsules are Halal approved by Halal Trust, Kosher approval by Rabbi Adler, and certification as vegan.
This milestone marks a significant step for the company, making HuxQ10 accessible to a wider audience.
Coenzyme Q10, or Q10, is a naturally occurring vitamin-like substance in the body, playing a crucial role in mitochondrial biogenetics and ATP production, which
is vital for cellular energy.
It also acts as a powerful antioxidant, capable of regenerating alpha-tocopherol, the active form of vitamin E.
In the pharmaceutical industry, maintaining high standards for water quality is crucial for ensuring product safety, efficacy, and compliance with
regulatory standards.
Water is a fundamental ingredient in drug manufacturing, and its quality directly impacts the production process and the end products. This makes adherence
to water service compliance a legal obligation and a critical aspect of operational integrity.
THE LEGAL COMPLICATIONS OF POOR WATER QUALITY
Compliance with water quality standards in the pharmaceutical industry is mandated by regulatory agencies such as the MHRA, several regulations that set
strict criteria for the types of water used, including purified water, water for injection, and sterile water.
Failure to meet these standards can result in severe penalties, including product recalls, fines, and loss of manufacturing licenses. Regulatory compliance
ensures the pharmaceutical companies adhere to legislations and avoid legal repercussions that can damage their reputation and financial standing
The Self-Care Strategy Group (SCSG) has written to Health Secretary, Wes Streeting, urging the new Labour government to fully realize self-care's benefits.
With PAGB serving as the secretariat for the Group, signatories of the letter also include CPE, RPS, CCA, NPA, the Dispensing Doctors' Association, the National
Association of Primary Care, the Patient Information Forum, and the Self Care Forum.
The nine members highlight the importance of collaborative efforts to build an NHS fit for the future.
In the letter, the group emphasises the potential of self-care to alleviate pressure on primary and emergency healthcare services.
They call for expanded prescribing rights, optimised digital health tools, and streamlined referral processes between primary, diagnostic, and specialist care
services.
Over the last few years, we've seen the aftermath of Covid-19, with the demand for consumer health products being unprecedented and unpredictable, placing
pressure on supply chains and labour market. In turn, the industry has experienced acute shortages across the healthcare sector, placing huge pressure on
pharmacists, doctors, nurses, and other healthcare professionals.
Europe has an estimated shortage of around 50,000 public-sector doctors[1], which is set to increase in the coming years. While this shortage stems from several
complex problems, there is a hidden force that could play a key part in helping to alleviate this burden. That force is the potential of self-care.
Encouragingly, last month the UK government recognised the unique role that self-care can play through the introduction of its Delivery plan for recovering access
to primary care. Through this, it has pledged to empower patients to manage their own health through several commitments, including improving accessibility to
online tools and reclassifying medicines to make formerly prescribed options available over the counter.
Pharma giant, Pfizer has announced plans to cut 500 jobs at its Sandwich site in Kent, England as part of its ongoing $3.5 billion cost-cutting drive.
The company is also planning to shut its Pharmaceutical Sciences Small Molecule (PSSM) capabilities at the site, a spokesperson of the company told FiercePharma.
However, the Sandwich site will remain open and other functions will continue with "a different size," the spokesperson added.
Currently, around 940 people are employed at the site, which is the location where Pfizer scientists first discovered Viagra.
"We are proud of our heritage of breakthrough science in the UK and we will retain a scientific presence in the U.K. including at our Discovery Park location
in Sandwich," Pfizer's spokesperson confirmed in an email to FiercePharma.
Health leaders have said that delivering faster and more productive patient care would be difficult unless NHS capital budgets are nearly doubled to
at least £14.1 billion from the current spending of £7.7 billion.
The NHS Confederation has highlighted the impact that low levels of capital investment have had over the last decade in its report published today (29 November).
The report, 'Investing to save: The capital requirement for a more sustainable NHS in England', revealed that the UK has lagged behind other comparable countries
in terms of health capital investment for more than five decades, resulting in less productivity.
It revealed that the NHS now has the sixth lowest number of CT and MRI scanners per million people of the OECD countries.